InsiderClue
Insiders · Profile

Soteropoulos Paula

Director at Dianthus Therapeutics, Inc. /DE/ · Director at uniQure N.V. Filing since 29 Jan 2018. CIK 0001692444

DNTH Dianthus Therapeutics, Inc. /DE/ Director · 3 trades QURE uniQure N.V. Director · 17 trades
Company
Date
Role
Action
Shares
Amount
Of holding
DNTH Dianthus Therapeutics, Inc. /DE/
8 May 2026
Director
Sold on a plan
599
$51.20K
100%
DNTH Dianthus Therapeutics, Inc. /DE/
31 Mar 2026
Director
Sold on a plan
599
$47.99K
100%
DNTH Dianthus Therapeutics, Inc. /DE/
24 Mar 2026
Director
Sold on a plan
27,594
$2.15M
100%
QURE uniQure N.V.
13 Jun 2024
Director
Sold at will
2,220
$11.41K
9.9%
QURE uniQure N.V.
16 Jun 2023
Director
Sold at will
2,275
$43.20K
9.2%
QURE uniQure N.V.
27 Feb 2023
Director
Sold, plan not stated
384
$7.67K
2.3%
QURE uniQure N.V.
18 Jan 2023
Director
Sold, plan not stated
6,000
$135.54K
26.8%
QURE uniQure N.V.
14 Dec 2022
Director
Sold, plan not stated
3,800
$89.03K
18.8%
QURE uniQure N.V.
13 Dec 2022
Director
Sold, plan not stated
3,000
$70.35K
15.5%
QURE uniQure N.V.
29 Nov 2022
Director
Sold, plan not stated
6,200
$157.36K
27.5%
QURE uniQure N.V.
28 Feb 2022
Director
Sold, plan not stated
596
$10.05K
7.5%
QURE uniQure N.V.
2 Mar 2021
Director
Sold, plan not stated
504
$18.95K
7.3%
QURE uniQure N.V.
5 Feb 2020
Director
Sold, plan not stated
2,122
$129.33K
46.7%
QURE uniQure N.V.
28 Jan 2020
Director
Sold, plan not stated
807
$50.19K
15.1%
QURE uniQure N.V.
7 Jan 2020
Director
Sold, plan not stated
3,000
$216.54K
35.9%
QURE uniQure N.V.
13 Dec 2019
Director
Sold, plan not stated
2,000
$141.00K
19.3%
QURE uniQure N.V.
9 Dec 2019
Director
Sold, plan not stated
2,500
$168.75K
23.0%
QURE uniQure N.V.
6 Dec 2019
Director
Sold, plan not stated
9,082
$583.60K
45.6%
QURE uniQure N.V.
28 Jan 2019
Director
Sold, plan not stated
1,210
$37.90K
5.7%
QURE uniQure N.V.
29 Jan 2018
Director
Sold, plan not stated
2,878
$53.33K
13.8%
20 decisions on file.